Marker Therapeutics Inc (FRA:GX1)
€ 4.96 0.3 (6.44%) Market Cap: 47.88 Mil Enterprise Value: 31.25 Mil PE Ratio: 0 PB Ratio: 4.24 GF Score: 48/100